CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1131 - 1140 of 1143
Study Number Lead Group Study Title CIRB Study Status
E2212 ECOG A Randomized; Double-Blinded; Placebo-Controlled Phase II Study of Adjuvant Everolimus Following the Resection of Metastatic Pancreatic Neuroendocrine Tumors to the Liver Adult CIRB - Early Phase Emphasis Completed
ANBL1221 COG A Phase II Randomized Trial of Irinotecan/Temozolomide with Temsirolimus (NSC# 683864; IND# 61010) or Chimeric 14.18 Antibody (ch14.18) (NSC# 764038; IND# 4308) in Children with Refractory; Relapsed or Progressive Neuroblastoma Pediatric CIRB Completed
S0502 SWOG A Phase III Randomized Study of Imatinib; with or without Bevacizumab (NSC-704865); in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors NCT #00324987 Adult CIRB - Late Phase Emphasis Completed
9974 ETCTN A phase II study of olaparib plus cediranib in combination with standard therapy for small cell lung cancer Adult CIRB - Early Phase Emphasis Completed
AHOD0431 COG A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin Disease Pediatric CIRB Completed
10437 ETCTN A Single Arm Phase II Study of Bone-targeted Sn-117m-DTPA in Symptomatic Castration Resistant Prostate Cancer with Skeletal Metastases Adult CIRB - Early Phase Emphasis Completed
CALGB-90106 CALGB A Randomized Phase III Study of Paclitaxel; Ifosfamide and Cisplatin Versus Vinblastine; Ifosfamide and Cisplatin as Second-Line Therapy for Patients with Relapsed/Resistant Germ Cell Tumors Adult CIRB - Late Phase Emphasis Completed
AREN0321 COG Treatment of High Risk Renal Tumors: A Groupwide Phase II Study Pediatric CIRB Completed
S0023 SWOG A Phase III Trial of Cisplatin/Etoposide/ Radiotherapy with Consolidation Docetaxel Followed by Maintenance Therapy with ZD1839 or Placebo in Patients with Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer Adult CIRB - Late Phase Emphasis Completed
A211601 Alliance Evaluation of Mammographic Breast Density Effect of Aspirin: A companion study to Alliance Study A011502 Cancer Prevention and Control CIRB Completed
Displaying 1131 - 1140 of 1143